Skip to content

Boston Scientific BSX Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$1.34B+99.3%$670M+19.2%$755M+61.3%$795M+147%$672M+36.3%
$351M+8.0%$365M+4.9%$342M+11.8%$336M+8.0%$325M+6.9%
$83M+12.2%$71M+2.9%$79M+16.2%$75M+13.6%$74M+17.5%
$348M-35.7%$1.36B-6.3%$1.34B+34.0%$1.29B+58.2%$541M+230%
$177M-5.3%$351M+26.7%$181M+1.1%$157M+1.3%$187M+4.5%
$523M+119%$89M-97.4%$256M-77.3%$1.01B+2,002%$239M+409%
-$591M-18.2%-$512M+86.2%-$502M+64.8%-$1.13B-315%-$500M-75.4%
-$260M-212%-$184M-186%-$104M-1,586%-$340M-1,517%$233M-85.1%
-$504M-261%$671M+133%$735M+278%$314M-78.2%
$171M-51.7%$1.01B-14.1%$1.16B+41.2%$1.13B+71.6%$354M+2,460%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Boston Scientific generate?
Boston Scientific (BSX) generated $4.3B in operating cash flow over the trailing twelve months.
What is Boston Scientific's free cash flow?
After $866.0M of capital expenditures, Boston Scientific's free cash flow was $3.5B over the trailing twelve months, up 15.3% year over year.
Where does Boston Scientific's cash flow data come from?
Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.